Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of Non-invasive Prenatal Diagnostic Test for Microdeletion/Microduplication and Other Genetic Disorders Based on Fetal DNA Isolated From Maternal Blood

NCT01852708 is registered in ClinicalTrials.gov with Natera, Inc. as lead sponsor.

NCT NCT01852708
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01852708 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of Non-invasive Prenatal Diagnostic Test for Microdeletion/Microduplication and Other Genetic Disorders Based on Fetal DNA Isolated From Maternal Blood
Lead sponsor
Natera, Inc.
Phase
Observational
Overall status
Completed
Start date
November 30, 2012
Completion date
October 31, 2020
Enrollment
1,059 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

microdeletion syndromes, sex chromosome abnormalities, trisomy 13, trisomy 18, trisomy 21